Related Experiment Video
Updated: Jul 10, 2025

A Doxorubicin-Induced Murine Model of Dilated Cardiomyopathy In Vivo
Published on: May 16, 2020
Cardiotoxicity Associated with Immune Checkpoint Inhibitors
Shintaro Minegishi1, Nobuyuki Horita2, Tomoaki Ishigami1
1Department of Cardiology, Yokohama City University Graduate School of Medicine, Yokohama 236-0004, Japan.
Immune checkpoint inhibitors (ICIs) demonstrate significant effectiveness across multiple cancer types. These therapies target key pathways to enhance the body's anti-tumor immune response.
Area of Science:
- Oncology
- Immunology
Background:
- Immune checkpoint inhibitors (ICIs) represent a significant advancement in cancer therapy.
- Their efficacy has been established in diverse malignancies such as lung cancer, melanoma, and renal cell carcinoma.
Discussion:
- ICIs function by blocking inhibitory pathways (e.g., PD-1/PD-L1, CTLA-4), thereby unleashing the patient's immune system against cancer cells.
- The broad applicability of ICIs across various cancer types underscores their fundamental role in modern oncology.
Key Insights:
- Demonstrated clinical success in non-small cell lung cancer, small cell lung cancer, melanoma, classical Hodgkin lymphoma, head and neck squamous cell carcinoma, urothelial cancer, and renal cell carcinoma.
- Highlighting the potential of immunotherapy to overcome treatment resistance in difficult-to-treat cancers.
Outlook:
- Ongoing research aims to expand the use of ICIs to other cancer types and patient populations.
- Future directions include combination strategies with other therapies to improve response rates and overcome resistance mechanisms.
More Related Videos
06:07Monitoring PD-1-Blocking Antibodies Bound to T Cells Derived from a Drop of Peripheral Blood
Published on: February 5, 2020
06:08Assessment of Chimeric Antigen Receptor T Cell-Associated Toxicities Using an Acute Lymphoblastic Leukemia Patient-Derived Xenograft Mouse Model
Published on: February 10, 2023
Related Concept Videos
Heart Failure Drugs: Inotropic Agents
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
Tumor Immunotherapy
Antiarrhythmic Drugs: Class II Agents as β-Adrenergic Blockers
Cytotoxic T Cells-mediated Immune Response
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
Heart Failure Drugs: Diuretics